Scholarlink

Background <p>Accurate in vivo assessment of rectal lesion invasion remains challenging despite advances in high-definition endoscopy and AI-assisted diagnostics. Some lesions resected endoscopically for presumed superficial pathology are ultimately found to contain submucosal invasive adenocarcinoma (pT1), prompting reconsideration of treatment. While total mesorectal excision (TME) remains the standard for radical oncologic removal, its morbidity has increased interest in organ-preserving approaches such as transanal endoscopic microsurgery (TEM).</p> Methods <p>We conducted a retrospective, single-centre study including all consecutive patients who underwent TEM after endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) of rectal lesions unexpectedly diagnosed as pT1 adenocarcinoma. Patients treated between 1995 and 2024 with at least 12&#xa0;months of follow-up were included. Primary endpoints were overall survival (OS) and disease-free survival (DFS); secondary endpoints included residual disease in the TEM specimen and patterns of recurrence.</p> Results <p>Sixty-six patients were included. TEM identified residual dysplasia in 25 patients (37.9%) but no cases of residual invasive carcinoma. Surgical margins were clear in all cases. Only one patient (1.5%) required salvage TME due to adverse histological features. At a median follow-up of 15&#xa0;months, OS was 100% and DFS 97%, with two patients (3%) experiencing local recurrence successfully managed with salvage surgery. No distant metastases were observed. No stoma formation or major complications occurred.</p> Conclusions <p>In patients with incidental pT1 rectal adenocarcinoma following EMR or ESD, completion TEM provides excellent short-term oncological outcomes with minimal morbidity. This two-step, organ-preserving approach appears oncologically adequate in well-selected low-risk patients and offers a viable alternative to radical surgery, especially when maintaining function is a priority.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Stepwise organ-preserving management of incidental pT1 rectal adenocarcinoma: outcomes after completion transanal endoscopic microsurgery (TEM)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月20日

查看全文
  • Alberto Arezzo,
  • Carlo Alberto Ammirati,
  • Giovanni Distefano,
  • Michele Barbiero,
  • Simone Arolfo,
  • Roberto Passera,
  • Mario Morino

摘要

Background

Accurate in vivo assessment of rectal lesion invasion remains challenging despite advances in high-definition endoscopy and AI-assisted diagnostics. Some lesions resected endoscopically for presumed superficial pathology are ultimately found to contain submucosal invasive adenocarcinoma (pT1), prompting reconsideration of treatment. While total mesorectal excision (TME) remains the standard for radical oncologic removal, its morbidity has increased interest in organ-preserving approaches such as transanal endoscopic microsurgery (TEM).

Methods

We conducted a retrospective, single-centre study including all consecutive patients who underwent TEM after endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) of rectal lesions unexpectedly diagnosed as pT1 adenocarcinoma. Patients treated between 1995 and 2024 with at least 12 months of follow-up were included. Primary endpoints were overall survival (OS) and disease-free survival (DFS); secondary endpoints included residual disease in the TEM specimen and patterns of recurrence.

Results

Sixty-six patients were included. TEM identified residual dysplasia in 25 patients (37.9%) but no cases of residual invasive carcinoma. Surgical margins were clear in all cases. Only one patient (1.5%) required salvage TME due to adverse histological features. At a median follow-up of 15 months, OS was 100% and DFS 97%, with two patients (3%) experiencing local recurrence successfully managed with salvage surgery. No distant metastases were observed. No stoma formation or major complications occurred.

Conclusions

In patients with incidental pT1 rectal adenocarcinoma following EMR or ESD, completion TEM provides excellent short-term oncological outcomes with minimal morbidity. This two-step, organ-preserving approach appears oncologically adequate in well-selected low-risk patients and offers a viable alternative to radical surgery, especially when maintaining function is a priority.